Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Travere Therapeutics Inc’s stock clocked out at $20.81, up 3.64% from its previous closing price of $20.08. In other words, the price has increased by $3.64 from its previous closing price. On the day, 1.51 million shares were traded. TVTX stock price reached its highest trading level at $20.91 during the session, while it also had its lowest trading level at $19.69.
Ratios:
To gain a deeper understanding of TVTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.04 and its Current Ratio is at 2.08. In the meantime, Its Debt-to-Equity ratio is 6.80 whereas as Long-Term Debt/Eq ratio is at 5.54.
On October 21, 2024, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight and also upped its target price recommendation from $9 to $27.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 11 ’25 when Cline Christopher R. sold 48 shares for $13.14 per share. The transaction valued at 631 led to the insider holds 89,990 shares of the business.
Christopher Cline bought 48 shares of TVTX for $631 on Apr 11 ’25. On Feb 12 ’25, another insider, ROTE WILLIAM E., who serves as the SENIOR VICE PRESIDENT, R&D of the company, sold 5,200 shares for $23.53 each. As a result, the insider received 122,356 and left with 98,519 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TVTX now has a Market Capitalization of 1847339008 and an Enterprise Value of 1877558784. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.92 while its Price-to-Book (P/B) ratio in mrq is 30.81. Its current Enterprise Value per Revenue stands at 8.052 whereas that against EBITDA is -8.83.
Stock Price History:
The Beta on a monthly basis for TVTX is 0.89, which has changed by 2.3782468 over the last 52 weeks, in comparison to a change of 0.09969199 over the same period for the S&P500. Over the past 52 weeks, TVTX has reached a high of $25.29, while it has fallen to a 52-week low of $5.30. The 50-Day Moving Average of the stock is 11.95%, while the 200-Day Moving Average is calculated to be 26.94%.
Shares Statistics:
It appears that TVTX traded 1.81M shares on average per day over the past three months and 1417980 shares per day over the past ten days. A total of 87.45M shares are outstanding, with a floating share count of 87.44M. Insiders hold about 1.50% of the company’s shares, while institutions hold 109.21% stake in the company. Shares short for TVTX as of 1744675200 were 11046107 with a Short Ratio of 6.10, compared to 1741910400 on 11194840. Therefore, it implies a Short% of Shares Outstanding of 11046107 and a Short% of Float of 12.529999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
